Scott Hurlbert, MD
Vascular Surgery · Colorado Springs, CONPI 1427038330
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Endologix LLC accounts for 61.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $293 and has fallen 59.9% since, to $117 in 2024. That places this record below the midpoint for vascular surgery clinicians in CO, where the typical reported total is $4,981.
Across 11 payments — averaging $60.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$408
- Boston Scientific$92
- Angiodynamics, Inc.$49
- Nevro Corp.$34
- Medtronic$34
- Medline Industries LP$22
- plus $21 from 1 others
What the payments were for
- Food & beverage$661100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 3 | $408 |
| Boston Scientific | 2 | $92 |
| Angiodynamics, Inc. | 1 | $49 |
| Nevro Corp. | 2 | $34 |
| Medtronic | 1 | $34 |
| Medline Industries LP | 1 | $22 |
| Smith+Nephew | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ovation$138
How this compares
$661 in reported general payments places this provider in the 15th percentile of 66 vascular surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 19 | $342 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Colorado Springs
- Melhem SharafuddinColorado Springs$46K
- William FryColorado Springs$28K
- Magdiel Trinidad HernandezColorado Springs$18K
- Carlos RuedaColorado Springs$13K
- David FeuerColorado Springs$12K
- Karl DittrichColorado Springs$10K
- David CorryColorado Springs$10K
- Gregory CarlsonColorado Springs$5K
- John ConnColorado Springs$4K
- Danielle SmithColorado Springs$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.